Avoiding intubation in the injured subglottis: the role of heliox therapy

Area of Science:

• Pediatric Critical Care
• Respiratory Medicine
• Emergency Medicine

Background:

• Intubation in children with severe viral tracheobronchitis or subglottic injury poses risks, including mucosal ischemia, scarring, subglottic stenosis, and failed extubation.
• These complications can necessitate tracheotomy, increasing morbidity.
• Identifying less invasive treatment options is crucial for pediatric airway management.

Observation:

• Heliox, a less dense gas mixture of helium and oxygen, reduces turbulent airflow.
• This study evaluated heliox as an initial therapy for 14 children with severe airway distress requiring intubation.
• Children presented with viral tracheobronchitis, subglottic stenosis exacerbation, or acute iatrogenic subglottic injury.

Findings:

• Heliox therapy successfully obviated the need for intubation in 10 out of 14 children (71%).
• Intubation was avoided, preventing potential mucosal injury and scarring.
• Heliox failure occurred in 4 children, 3 of whom had a history of subglottic stenosis.

Implications:

• Heliox represents a safe and reliable alternative to intubation for selected pediatric patients with severe subglottic edema or injury.
• Considering heliox before intubation may prevent adverse outcomes associated with invasive airway management.
• Further research can explore optimal patient selection for heliox therapy in pediatric airway emergencies.